Next Article in Journal
Efficacy and Mechanism of Action of Marine Alkaloid 3,10-Dibromofascaplysin in Drug-Resistant Prostate Cancer Cells
Next Article in Special Issue
Metabolites of Marine Sediment-Derived Fungi: Actual Trends of Biological Activity Studies
Previous Article in Journal
Oxygenated Theonellastrols: Interpretation of Unusual Chemical Behaviors Using Quantum Mechanical Calculations and Stereochemical Reassignment of 7α-Hydroxytheonellasterol
Previous Article in Special Issue
Hatsusamides A and B: Two New Metabolites Produced by the Deep-Sea-Derived Fungal Strain Penicillium steckii FKJ-0213
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 18
Issue 12
10.3390/md18120608
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Neuroprotective Metabolites from Vietnamese Marine Derived Fungi of Aspergillus and Penicillium Genera

by
Elena V. Girich
1,
Anton N. Yurchenko
1,*,
Olga F. Smetanina
1,
Phan Thi Hoai Trinh
2,
Ngo Thi Duy Ngoc
2,
Mikhail V. Pivkin
1,
Roman S. Popov
1,
Evgeny A. Pislyagin
1,
Ekaterina S. Menchinskaya
1,
Ekaterina A. Chingizova
1,
Shamil S. Afiyatullov
1 and
Ekaterina A. Yurchenko
1
1
G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far Eastern Branch of Russian Academy of Sciences, 690950 Vladivostok, Russia
2
Department of Marine Biotechnology, Nhatrang Institute of Technology Research and Application, Vietnam Academy of Science and Technology, Nha Trang 650000, Vietnam
*
Author to whom correspondence should be addressed.
Mar. Drugs 2020, 18(12), 608; https://doi.org/10.3390/md18120608
Submission received: 12 November 2020 / Revised: 25 November 2020 / Accepted: 28 November 2020 / Published: 30 November 2020
(This article belongs to the Special Issue Bioactive Compounds from Marine Sediment Derived Fungi)
Browse Figures
Versions Notes

Abstract

:
Low molecular weight secondary metabolites of marine fungi Aspergillus flocculosus, Aspergillus terreus and Penicillium sp. from Van Phong and Nha Trang Bays (Vietnam) were studied and a number of polyketides, bis-indole quinones and terpenoids were isolated. The structures of the isolated compounds were determined by 1D and 2D NMR and HR-ESI-MS techniques. Stereochemistry of some compounds was established based on ECD data. A chemical structure of asterriquinone F (6) was thoroughly described for the first time. Anthraquinone (13) was firstly obtained from a natural source. Neuroprotective influences of the isolated compounds against 6-OHDA, paraquat and rotenone toxicity were investigated. 4-Hydroxyscytalone (1), 4-hydroxy-6-dehydroxyscytalone (2) and demethylcitreoviranol (3) have shown significant increasing of paraquat- and rotenone-treated Neuro-2a cell viability and anti-ROS activity.

Graphical Abstract

1. Introduction

Marine fungi have to adapt to difficult environments and therefore they have a unique secondary metabolism that differs from terrestrial strains [1,2]. For instance, entomopathogenic fungus Beauveria (Isaria) felina usually produces a big variety of insecticide depsipeptides [3] but its marine strain was a source of rare oxygenated isochromenes and unique cytotoxic α-unsubstituted pyran polyketides [4]. Moreover, marine areas differ in a number of characteristics (salinity, depth, content of nutrients and organic compounds in the water), and therefore, fungi isolated from different seas can also produce different substances [5].
Van Phong and Nha Trang Bays are located in the central part of the Vietnamese coastline of the South China Sea [6]. Water in these sea areas is warm, and the temperature ranges from 23 °C in January up to 28 °C in May–June due to being closely connected with a monsoon climate. Salinity of coastal waters is close to the ocean normal one, ranging from 32‰ to 34‰. The living conditions of these bays are ideal for most marine organisms in the tropics [7,8]. Moreover, the coral reefs of these bays are unique due to connection with the open sea and wave action, thereby leading to the formation of reefs of inner bays and straits, and reefs of open capes and islands [9]. In particular, the coral reefs in Nha Trang and Van Phong Bays are considered as high diverse ecosystems with many valuable marine micro- and macroorganisms producing various bioactive compounds [8,10].
The marine sediment-derived strain Beauveria (Isaria) felina from Van Phong Bay was reported as a source of highly oxygenated chromene derivatives oxirapentyns with cytotoxic activity against a number of cancer cell lines [11] and unique prostate cancer-toxic polyketide isariketide A [12]. Moreover, coincubation of B. felina with Aspergillus sulphureus KMM 4640 resulted in isolation of oxirapentyn L [12] and cytotoxic diorcinol J [13].
The strain Aspergillus terreus from a sample of Zoantharia coral collected on the shores of Van Phong Bay was found as a source of questin and terrein [14]. It was the first report about terrein-induced enhancement of a heat shock protein 70 kDa (Hsp70) expression.
Marine fungus Aspergillus niveoglaucus from the sediment sample collected from Nha Trang Bay was reported as a source of polyketides niveoglaucin A and flavoglaucin and a number of echinulin-related compounds that demonstrated antioxidant and neuroprotective effects in different in vitro Parkinson’s disease models [15,16].
Marine fungus Penicillium sp. KMM 4672 isolated from brown alga Padina sp. (Van Phong Bay) was reported as a source of melatonin analogue 6-hydroxy-N-acetyl-β-oxotryptamine, 3-methylorsellinic acid and 8-methoxy-3,5-dimethylisochroman-6-ol, which effectively protected Neuro-2a cells against 6-hydroxydopamine (6-OHDA)-induced neuronal death [17].
The strain Aspergillus flocculosus from a sediment sample (Nha Trang Bay) produced drimane derivative 6β,9α,14-trihydroxycinnamolide and 9α,14-dihydroxy-6β-p-nitrobenzoylcinnamolide with high cytotoxic activity against mouse Neuro-2a and human 22Rv1 and MCF-7 line cells [18]. Moreover, diketopiperazine mactanamide from this strain has shown influence on osteoclast differentiation [19] and the fungistatic effect [20] and radical scavenging [21], antioxidant and neuroprotective activities in 6-OHDA-treated cell model of Parkinson’s disease [17].
Thus, there are a few examples of reports about marine fungi from Van Phong and Nha Trang Bays (similar to other parts of Vietnamese coast) as producers of bioactive metabolites including neuroprotective compounds.
To upgrade our knowledge in this field, we continue to investigate the secondary metabolites of Penicillium sp. KMM 4672 and A. flocculosus and a new strain of A. terreus isolated from leaves of an unidentified mangrove tree. Neuroprotective effects of isolated compounds were studied in different toxin-induced cell models of Parkinson’s disease.

2. Results

2.1. Isolation and Identification of Compounds

The thoroughly chromatographic separation of medium-polarity fractions of Penicillium sp. KMM 4672 with silica gel, sephadex LH-20 and subsequent reversed-phase HPLC to afford 1–4. The structure of 4-hydroxy-3,6-dimethyl-2-pyrone (4) was earlier reported by us [22], whereas planar structures of compounds 1-3 were established by 1D and 2D NMR and high resolution electrospray ionization mass-spectrometry (HR-ESI-MS) and found to be reported as 4-hydroxyscytalone (1) [23], 4-hydroxy-6-dehydroxyscytalone (2) [24] and demethylcitreoviranol (3) [25].
Relative configurations of 3-OH and 4-OH of compounds 1 were determined as anti based on 3JH3-H4 = 7.1 Hz [23,26], and its absolute stereochemistry was suggested as 3S,4S based on a comparison of the optical rotation value ([α]D20 +73°) with literature data ([α]D20 −75° [23] and [α]D20 +58° [27]). Finally, the structure of 1 was established as (3S,4S)-4-hydroxyscytalone.
Relative configurations of aliphatic hydroxy groups at C-3 and C-4 in 4-hydroxy-6-dehydroxyscytalone (2) were established as anti based on 3JH3-H4 = 6.4 Hz. Absolute stereochemistry of 2 was determined as 3S,4S by comparison of its experimental CD data (Supplementary Materials, Figure S7) with literature data [27] and experimental CD data for 1 (Supplementary Materials, Figure S3). Thus, the structure of 2 was established as (3S,4S)-4-hydroxy-6-dehydroxyscytalone.
The vicinal coupling constants between H-2’ and H-3’a (3J = 11.8 Hz), H-2’ and H-3’b (3J = 2.1 Hz), H-3’a and H-4’ (3J = 11.8 Hz) and H-4’ and H-5’a (3J = 11.1 Hz) and W-type coupling constant between H-3’b and H-5’b (5J = 11.1 Hz) and comparing these data with literature values [28] revealed a relative stereochemistry of demethylcitreoviranol (3) as depicted (Figure 1). Unfortunately, we were not able to determine an absolute stereoconfigurations of 3 due to an insufficient amount of this compound.
A chemical composition of sediment-derived fungus Aspergillus flocculosus was recently studied by us and reported earlier [18]. Dihydroaspyrone (5) was the main metabolite of the extract of this fungus.
The fungus Aspergillus terreus LM.1.5 was cultivated for 21 days on modified rice medium. The dry EtOAc extract of the culture was separated successively over a column of silica gel and by normal-phase and reversed-phase HPLC to afford pure compounds 6–16 (Figure 1).
Pseudo-molecular peak [M+Na]+ at m/z 439.1257 in the (+)-HR-ESI-MS spectrum of 6 suggested the molecular formula as C24H20N2O5 (calculate for C24H20N2O5Na, 439.1264), which was confirmed by NMR data. A thorough analysis of 1H and 13C NMR spectra together with DEPT and HSQC data (Table 1) indicated the presence of two methoxy groups (δC 61.5, 60.4; δH 4.12, 3.58), one oxygen-bearing sp3-metine carbon (δC 104.6; δH 6.24), one oxygenated quaternary sp3-carbon (δC 90.3), nine sp2-methine carbons (δC 130.1, 125.0, 124.8, 122.7, 120.4, 120.3, 120.1, 111.4, 109.9; δH 7.78, 7.47, 7.43, 7.29, 7.24, 7.18, 7.14, 6.88, 6.70), 11 quaternary sp2-carbons (δC 148.6, 144.9, 141.3, 139.1, 138.3, 136.2, 129.7, 126.5, 121.6, 116.7, 106.7) and two heteroatom-bonded protons (δH 8.44, 5.06).
HMBC correlations (Figure 2a) from 1”-NH (δH 8.44) to C-3” (δC 106.7), C-3a’’ (δC 126.5), from H-2” (δH 7.29) to C-3” (δC 106.7), C-3a’’ and C-7a’’ (δC 136.2), from H-4” (δH 7.47) to C-3”, C-6” (δC 122.7) and C-7a’’, from H-5” (δH 7.14) to C-3a’’ and C-7” (δC 111.4), from H-6” (δH 7.24) to C-4” (δC 120.3) and C-7a’’, from H-7” (δH 7.43) to C-3a’’ and C-5” (δC 120.4) and 1H-1H COSY correlations (Figure 2a) between 1”-NH/H-2”, H-4”/H-5”, H-5”/H-6” and H-6”/H-7” indicated the presence of a monosubstituted indole fragment. HMBC correlations (Figure 2b) from H-2’ (δH 6.24) to C-3’ (δC 90.3), C-3a’ (δC 129.7) and C-7a’ (δC 148.6), from H-4’ (δH 7.78) to C-3’, C-7a’ and C-6’ (δC 130.1), from H-5’ (δH 6.88) to C-3a’, C-7’ (δC 109.9), from H-6’ (δH 7.18) to C-4’ (δC 125.0) and C-7a’, from H-7’ (δH 6.70) to C-3a’ and C-5’(δC 120.1), 1H-1H COSY correlations (Figure 2b) between H-4’/H-5’, H-5’/H-6’, and H-6’/H-7’ and value of chemical shifts of C-2’ (δC 104.6) and C-3’ indicate of the presence of disubstituted indoline moiety. The remaining signals of quaternary sp2-carbons (C-1, δC 141.3; C-2, δC 116.7; C-3, δC 138.4; C-4, δC 144.9; C-5, δC 121.6 and C-6, δC 139.1) and HMBC correlations (Figure 2c) namely from 6-OMe (δH 4.12) to C-6, from 3-OMe (δH 3.58) to C-3, from 1-OH (δC 5.06) to C-1, C-2 and C-6 were assigned to the 1,4-dimethoxy-6-hydroxybenzene ring. The joint of indoline and benzene moieties has been proven with HMBC correlations (Figure 2d) from H-2’ to C-3 and C-4, and values of chemical shifts of C-3, C-4, C-2’ and C-3’. Thus, the structure of a tetracyclic system consists of indoline-benzofuran fragment was established. HMBC correlations from H-2” to C-2 indicated the structure of bis-indolebenzofuran-derivative.
A direct comparison of the NMR data of 6 with literature data for known varioloid D [29,30] revealed the close similarities, except the signals of C-1, C-2, C-4, C-6 and C-3” in 6. These data proved the presence of a tetracyclic system formed via a reduction of C-2’ and C-3’ in indole moiety followed by cyclization at C-4 and C-2’. Thus, compound 6 has a planar structure 3-(1H-indol-3-yl)-1,4-dimethoxy-5a,6-dihydro-10bH-benzofuro [2,3-b]indole-2,10b-diol. Absolute configurations of stereocenters at C-2’ and C-3’ in 6 were determined based on a comparison of experimental ECD data of 6 with those for closely related known varioloid C [29,30]. Compound 6 was named asterriquinone F. It should be noted that a compound with this planar structure was once reported by Arai and Yamamoto [31] as the unnamed derivative of asterriquinone D. Nevertheless, these authors have not provided reliable structure elucidation evidence. The similarity of optical rotation values of asterriquinone F (6) and the unnamed compound from Arai and Yamamoto’s report (+47 and +39, respectively) may indicate an identity of these compounds. In addition, another Arai and Yamamoto’s paper proved an origin of asterriquinone F (6) via oxidation of asterriquinone D (11) [32].
Besides asterriquinone F (6), 10 known compounds were isolated from A. terreus. They were identified using NMR and MS analysis as asterriquinones A3 (7), B4 (8), C1 (9), C2 (10) and D (11) [33], questin (12) [34,35], 1,2,5-trihydroxy-7-methyl-9,10-antraquinone (13) [36], 4-hydroxy-3-(3-methylbut-2-enyl)benzaldehyde (14) [37,38], quadrone (15) [39] and 6β-hydroxyergosta-4,7,22-trien-3-on (16) [40]. It should be noted that antraquinone (13) was reported once as a byproduct in nataloe-emodin synthesis [36].
Unfortunately, compounds 13–16 were obtained in insufficient amounts and were not studied for biological activities.

2.2. Biological Activities of the Studied Compounds

The neuroprotective activity of the compounds in Parkinson’s disease (PD) in vitro models was investigated in murine malignant Neuro-2a cells, which are widely used for this purpose [41,42]. Firstly, all investigated compounds were tested on cytotoxicity against neuroblastoma Neuro-2a cells (Table 2).
Compounds 1–7 and 10–12 did not show any influences on Neuro-2a cell viability up to 100 µM. Quinones 8 and 9 were more effective in this assay and demonstrated cytotoxic activity with IC50 at 91.45 and 42.32 µM, respectively.

2.2.1. 4-Hydroxyscytalone (1), 4-Hydroxy-6-Dehydroxyscytalone (2) and Demethylcitreoviranol (3)

Compounds 1–3 did not affect viability of Neuro-2a cells incubated with 6-OHDA but they were significantly active in paraquat (PQ)- and rotenone-induced PD cell models (Figure 3). PQ decreased the Neuro-2a cell viability by 44% and compounds 1–3 increased the viability of PQ-treated cells by 41.8%, 22.8% and 34.3%, respectively (Figure 3c). Rotenone decreased the viability of Neuro-2a cells by 48% and compounds 1–3 increased the viability of rotenone-treated cells by 50.9%, 79.1% and 65.2%, respectively (Figure 3e).
Moreover, the influence of investigated compounds on the ROS level in neurotoxin-treated cells was tested. 6-OHDA, PQ and rotenone increased an intracellular ROS level by 66% (Figure 3b), 48% (Figure 3d) and 79% (Figure 3f), respectively. Compounds 1 and 2 decreased a ROS level in all used PD cell models (Figure 3b,d,f) whereas 3 was effective against ROS level enhancing in PQ- and rotenone-induced PD models only. At the same time, radical scavenging activity of 1–3 in cell-free assay was not significant (Table 2).

2.2.2. 4-Hydroxy-3,6-Dimethyl-2-Pyrone (4) and Dihydroaspyrone (5)

4-Hydroxy-3,6-dimethyl-2-pyrone (4) and dihydroaspyrone (5) were not cytotoxic against neuroblastoma Neuro-2a cells up to 100 µM (Table 2).
4-Hydroxy-3,6-dimethyl-2-pyrone (4) and dihydroaspyrone (5) did not demonstrate any protective effects against 6-OHDA (Figure 4a). Compound 5 statistically increased the viability of PQ-treated cells by 21.9% whereas 4-hydroxy-3,6-dimethyl-2-pyrone (4) had no effect on viability. These data are consistent with the effect of compounds 4 and 5 on the intracellular ROS level (Figure 4d). Pyrone 4 had almost no effect in this test, while 5 significantly reduced the ROS level in PQ-treated Neuro-2a cells.
Quite unexpectedly, pyrones 4 and 5 did not affect rotenone-treated Neuro-2a cell viability (Figure 4e) since they both significantly reduced the ROS level in these cells (Figure 4f). It was reported earlier, that dihydroaspyrone 5 showed radical scavenging activity with half-maximal effective concentration at 500 μM. In our study both pyrones did not show significant antiradical activity (Table 2).

2.2.3. Asterriquinones (6–11) and Questin (12)

The cytotoxic activity of compounds 6–12 toward Neuro-2a cells were studied and asterriquinones B4 (8) and C1 (9) and questin (12) showed half-maximal toxic effect at 91.45, 42.32 and 105.36 µM (Table 2). So, compounds 6–12 were investigated in PD in vitro models at a nontoxic concentration of 1 µM.
Asterriquinone A3 (7) showed a weak cytoprotective activity in 6-OHDA-induced PD cell model (Figure 5a). Additionally, asterriquinone B4 (8) protected Neuro-2a cells against all used neurotoxins and increased cell viability by 36.3% (Figure 5a), 18.4% (Figure 5c) and 34.8% (Figure 5e). Other investigated asterriquinones 6 and 9–11 were inactive in these assays. Nevertheless, all investigated asterriquinones decreased the ROS level in 6-OHDA-, PQ- and rotenone-treated Neuro-2a cells (Figure 5b,d,f).
Questin (12) showed moderate cytoprotective activity in the rotenone-induced PD cell model and increased the viability of cells by only 23.7% (Figure 5e). At the same time, 12 was inactive against 6-OHDA and PQ neurotoxicity while the significant in vitro anti-ROS activity of 12 was found (Figure 5b,d,f). Earlier DPPH-radical scavenging activity has been reported for questin (12) however no exact data have been published [44]. In our investigation 12 did not show any significant DPPH radical scavenging up to 100 μM (Table 2).

3. Discussion

4-Hydroxyscytalone (1) is a well-known metabolite intermediate of pentaketide pathway of melanin biosynthesis [45]. Melanin occurs in the cell walls of many fungi. Melanized fungal cells survive desiccation and ultraviolet irradiation notably better than their hyaline counterparts. The ability of certain fungi to produce melanin also appears to be an important determinant of pathogenicity. Known intermediates in the pentaketide melanin pathway include 1,3,6,8-tetrahydroxynaphthalene (1,3,6,8-THN) formed via pentaketide precursor cyclization, scytalone, 1,3,8-trihydroxynaphthalene (1,3,8-THN), vermelone and l,8-dihydroxynaphthalene (DHN). 4-Hydroxyscytalone (1) is formed via hydrogenation of 1,2,4,5,7-pentahydroxynaphtalene (1,2,4,5,7-PHN), which is a redox product of 1,3,6,8-THN. 4-Hydroxy-6-dehydroxyscytalone (2) also known as 3,4,8-trihydroxynaphtalene (3,4,8-THN) may be produced via hydrogenation and dehydration of 1,2,4,5,7-PHN or from scytalone via its dehydration and subsequent oxygenation and hydrogenation [45].
Pentaketides 1 and 2 were isolated from fungi several times [46,47], and described as phytotoxic [48,49] and antinematodal agents [50]. Cytotoxicity of 4-hydroxyscytalone (1) against four tumor cell lines, including MCF-7, HepG-2, NCI-H460 and SF-268 and some others was investigated, but no activity was shown [27,51,52]. Moreover, a weak antimicrobial activity against Escherichia coli and Bacillus subtilis was reported for 1 [53]. Despite a relationship of 1 and 2 with melanin, their protective properties toward PQ and rotenone cytotoxicity are described for the first time.
Demethylcitreoviranol (3) have been reported only twice [25,54]. It was investigated in the ARE luciferase assay and showed a weak inducing of the Nrf2-ARE pathway, which may suppress of oxidative genes and oxidative stress induced neurodegenerative diseases and carcinogenesis [54]. This has been confirmed in PQ- and rotenone-induced PD cell models.
The structural differences between 1 and 3 did not affect their neuroprotective activity. Probably, 1-naphtalenone or geometrically similar isocoumarine core is of great importance for the neuroprotective effect of these compounds against PQ and rotenone toxicity.
The lack of protective effect of 1–3 against the 6-OHDA-induced neuronal damage is apparently associated with a different mechanism of 6-OHDA, PQ and rotenone actions. All these neurotoxins cause oxidative stress and enhance ROS accumulation in cells. 6-OHDA induces oxidative stress both during its autoxidation to p-quinone and, also, during one-electron reduction of p-quinone to p-semiquinone, catalyzed by flavoenzymes that transfer one electron. PQ causes generation of intracellular free radicals via reducing of the divalent paraquat ion (PQ2+) to monovalent paraquat ion (PQ+) by NADPH-oxidase of mitochondrial complex I and reestablishing a new redox reaction by PQ+. In turn, rotenone was reported as a direct inhibitor of mitochondrial complex I. Thus, neuroprotective activity of compounds 1-3 is due not so much to the ROS scavenging (since it decreased intracellular ROS level in all three PD models), but also to the influence on some other aspects of PQ and rotenone neurotoxicity.
4-Hydroxy-3,6-dimethyl-2-pyrone (4) earlier was tested for antibacterial activities (methicillin-resistant Staphylococcus aureus (MRSA), S. aureus, Enterococcus faecalis and Acinetobacter baumannii, E. coli and Klebsiella pneumonia) and cytotoxic activities against K562, BEL-7042, SGC-7901, A-549 and Hela cell lines and was ineffective [55]. In addition, it demonstrated a weak cytotoxicity against murine lymphoma L5178Y cell line [56]. As it was reported by Abe at al. 4 shows DPPH radical scavenging activity via donation of a hydrogen atom to DPPH radical and forming adduct with DPPH radical [57]. We suggest this mechanism may be realized in PQ-treated Neuro-2a cells. Differences between the mechanism of ROS generation by 6-OHDA, PQ and rotenone resulted in this fact that 4 reduced the ROS level in PQ-treated cells only.
Dihydroaspyrone (5) earlier showed a weak cytotoxicity against HeLa [58], while it did not show cytotoxicity against a number of other cell lines [59,60] and antimicrobial activity against several microbial pathogens [59,61]. In present study 5 reduced ROS level in all neurotoxin-treated Neuro-2a cells but it statistically increased viability of PQ-treated cells only. Additional hydroxylation of 5 compared with 4 may play a key role for realizing of anti-ROS activity of 5 in neurotoxin-induced PD cell models.
It was earlier published that synthetic analogues of the asterriquinones, 1H5 and 5E5, have activated TrkA tropomyosin receptor kinase A directly in the cells and protected differentiated PC12 cells (rat adrenal pheochromocytomas) or contributed to the differentiation of neurons [62,63].
In our investigation only asterriquinone B4 (8) showed a significant neuroprotective activity among studied quinones. Probably, C-2 reverse-prenylated indole is the key moiety for neuroprotective properties of asterriquinones. Thus, asterriquinones A3 (7) and C1 (9) with one C-2 reverse-prenylated indole moiety was much less active compared with symmetric asterriquinone B4 (8). Other asterriquinones without this moiety were inactive. Recently we reported that other C-2 reverse-prenylated indole containing fungal metabolites increased rotenone- and PQ-treated Neuro-2a cells viability [16].
Thus, neuroprotective effects of asterriquinone B4 (8) and questin (12) from A. terreus in toxin-induced PD cell models were found at the first time. Earlier some butenolides and butyrolactone I from tropical strains A. terreus were reported as antineuroinflammatory compounds [64,65]. Moreover, butyrolactones I and VII from A. terreus exhibited protective activity against the glutamate-induced excitotoxicity [66]. Butyrolactone aspernolide F from endophytic strain A. terreus shown protective activity against doxorubicin-induced cardiotoxicity [67].
Metabolism of marine fungi is focused on survival in difficult highly competitive environments. For this reason, antimicrobial and cytotoxic fungal metabolites were the main goal of researchers during many years [68]. At the same time, the presence of cytoprotective compounds also should help fungi to successfully compete with bacteria in microbial communities. However, the cytoprotective potential of marine fungi is unappreciated today and these research are quite promising.

4. Materials and Methods

4.1. General

Optical rotations were measured on a Perkin-Elmer 343 polarimeter (Perkin Elmer, Waltham, MA, USA). UV spectra were recorded on a Specord UV VIS spectrometer (Carl Zeiss, Jena, Germany) in MeOH. CD spectra were measured with a Chirascan-Plus CD spectrometer (Applied Photophysics, Leatherhead, United Kingdom) in MeOH. NMR spectra were recorded in CDCl3, acetone-d6 and DMSO-d6 with Bruker DPX-500 (Bruker BioSpin GmbH, Rheinstetten, Germany) or Bruker DRX-700 (Bruker BioSpin GmbH, Rheinstetten, Germany) spectrometers using TMS as an internal standard. HR-ESI-MS spectra were measured on a Maxis impact mass spectrometer (Bruker Daltonics GmbH, Rheinstetten, Germany).
Low-pressure liquid column chromatography was performed using silica gel (50/100 μm, Imid, Russia) and SephadexTM LH-20 (GE Healthcare, Uppsala, Sweden). Plates (4.5 cm × 6.0 cm) precoated with silica gel (5–17 μm, Imid) and silica gel 60 RP-18 F254S (20 cm × 20 cm, Merck KGaA, Darmstadt, Germany) were used for thin-layer chromatography. Preparative HPLC was carried out with a Shimadzu LC-20 chromatograph (Shimadzu USA Manufacturing, Canby, OR, USA) using YMC ODS-AM (YMC Co., Ishikawa, Japan; 5 µm, 10 mm × 250 mm) and YMC SIL (YMC Co., Ishikawa, Japan) (5 µm, 10 mm × 250 mm) columns with a Shimadzu RID-20A refractometer (Shimadzu Corporation, Kyoto, Japan) and with an Agilent 1260 Infinity II chromatograph (Agilent Technologies, Waldbronn, Germany) using a Supelco Discovery C-18 column (Sigma-Aldrich Co. LLC, Bellefonte, PA, USA) (5 µm, 4.6 mm × 250 mm) with an Agilent 1260 Infinity II UV detector (Agilent Technologies, Waldbronn, Germany).

4.2. Fungal Strains

The strain Penicillium sp. KMM 4672 was isolated from a brown alga Padina sp. (Van Phong Bay, South China Sea, Vietnam) on malt extract agar, and identified on the basis of morphological and molecular features, as described earlier [69].
The strain Aspergillus flocculosus was isolated from a sediment sample (Nha Trang Bay, South China Sea, Vietnam) by inoculating on the modified Sabouraud medium and on the basis of morphological and molecular features, as described earlier [17].
The strain of Aspergillus terreus was isolated from leaves of the unidentified mangrove tree collected in Khanh Hoa province (Vietnam, South China Sea) by inoculating on the modified Sabouraud medium (peptone 10 g, glucose 20 g, agar 18 g, natural sea water 1000 mL, penicillin 1.5 g and streptomycin 1.5 g, pH 6.0–7.0). The fungus was identified according to a molecular biological protocol by DNA amplification and sequencing of the ITS region (GenBank accession number MN788658.1). BLAST search results indicated that the sequence was 98.06% identical (858/875 bp) with the sequence of Aspergillus terreus strain DTO 403-C9 (GenBank accession number MT316343.1). The strain is stored at the collection of microorganisms of the Nha Trang Institute of Technology and Research Application VAST (Nha Trang, Vietnam) under the code LM.5.2

4.3. Cultivation of the Fungi

All the fungal strains were cultured at room temperature for three weeks in 60 × 500 mL Erlenmeyer flasks each containing rice (20.0 g), yeast extract (20.0 mg), KH2PO4 (10 mg) and natural seawater (40 mL).

4.4. Extraction and Isolation

The main part of the isolation procedures of compounds from Penicillium sp. KMM 4672 was described in a previous paper [22]. The n-hexane–EtOAc (85:15, 380.0 mg) fraction was separated by a sephadex LH-20 column (80 cm × 2 cm) with CHCI3-EtOH (1:1) and then purified by HPLC on an YMC ODS-AM column, eluting with MeCN–H2O (45:55) to yield 2 (5.6 mg). The n-hexane–EtOAc (80:20, 150.0 mg) fraction was separated by a sephadex LH-20 column (80 cm × 2 cm) with CHCI3-EtOH (1:1) and then purified by HPLC on an YMC ODS-AM column, eluting with MeOH–H2O (65:35) and MeCN–H2O (45:55) to yield 3 (2.0 mg). The n-hexane–EtOAc (70:30, 190.0 mg) fraction was separated by a sephadex LH-20 column (80 cm × 2 cm) with CHCI3-EtOH (1:1) and then purified by HPLC on an YMC ODS-AM column, eluting with MeOH–H2O (65:35) to yield 1 (1.9 mg). The isolation of compound 4 was described in a previous paper [22].
The isolation of compound 5 from Aspergillus flocculosus was described in a previous paper [18].
The fungal mycelia of Aspergillus terreus with the medium were extracted for 24 h with 12.0 L of EtOAc. Evaporation of the solvent under reduced pressure gave a dark brown oil (2.7 g). To this residue was added 150 mL of H2O-EtOH (4:1), and the mixture was thoroughly stirred to yield a suspension. The suspension was sequentially extracted with hexane (100 mL × 3), EtOAc (150 mL × 3) and n-BuOH (150 mL × 2). The EtOAc fraction was concentrated under reduced pressure to give a dry residue (1.6 g), which was separated on a silica gel column (20.0 cm × 4 cm) eluted with a hexane-EtOAc gradient (1:0→0:1). The hexane-EtOAc fraction AT-1-5 (95:5, 564.72 mg) was separated using Sephadex LH-20 eluting with chloroform and by HPLC on an YMC ODS-AM column in MeCN-H2O (70:30) to yield 13 (1.00 mg) and 14 (1.30 mg). The hexane-EtOAc fraction AT-1-9 (95:5, 38.96 mg) was separated using Sephadex LH-20 eluting with chloroform and subsequent HPLC separations on an YMC SIL column in EtOAc-n-hexane (25:75) and EtOAc-n-hexane (30:70), and on an YMC ODS-AM column in MeCN-H2O (90:10), to yield 7 (1.43 mg). The hexane-EtOAc fraction AT-1-19 (90:10, 47.70 mg) was separated sequentially on a column with Sephadex LH-20 in CHCl3 and by HPLC on an YMC-SIL column in EtOAc-n-hexane (20:80) and EtOAc-CHCl3 (5:95) to yield 8 (2.70 mg), 15 (1.94 mg) and 16 (0.70 mg). The hexane-EtOAc fraction AT-1-14 (90:10, 82.31 mg) was separated using Sephadex LH-20 eluting with chloroform to yield 12 (1.80 mg). The hexane-EtOAc fraction AT-1-26 (85:15, 135.00 mg) was separated using Sephadex LH-20 eluting with chloroform and purified by HPLC on an YMC ODS-AM column in MeCN-H2O (70:30) to yield 9 (2.50 mg). The hexane-EtOAc fraction AT-1-30 (85:15, 154.00 mg) was separated using Sephadex LH-20 eluting with chloroform and purified by HPLC on an YMC ODS-AM column in MeCN-H2O (70:30) to yield 10 (2.80 mg). The hexane-EtOAc fraction AT-1-105 (65:35, 267.18 mg) was separated using Sephadex LH-20 eluting with chloroform to yield 11 (9.90 mg). The hexane-EtOAc fraction AT-101-69 (75:25, 154 mg) was separated using Sephadex LH-20 eluting with chloroform and purified by HPLC on an YMC ODS-AM column in MeCN-H2O (75:25) and then on a Supelco C-18 column in MeOH-H2O gradient (1:1→1:0) to yield 6 (2.44 mg).
(3S,4S)-4-hydroxyscytalone (1): White powder; [ α ] D 20 +73° (c 0.04, MeOH); UV (MeOH) λmax (logε) 313 (3.60), 283 (3.90), 234 (3.77), 216 (3.98); CD (0.71 mM, MeOH) λmax (Δε) 195 (+0.77), 215 (−4.82), 241 (+0.52), 280 (+1.36), 315 (+0.13); 1H and 13C-NMR data, see Supplementary Data (Figures S1 and S2); HR-ESI-MS [M – H]– 209.0457 (calcd for C10H9O5, 209.0455).
(3S,4S)-4-hydroxy-6-dehydroxyscytalone (2): White powder; [ α ] D 20 +29° (c 0.22, MeOH); UV (MeOH) λmax (logε) 333 (3.45), 259 (3.82), 216 (4.15); CD (0.96 mM, MeOH) λmax (Δε) 196 (+0.93), 215 (−8.59), 231 (+0.28), 259 (+3.20); 1H and 13C-NMR data, see Supplementary Data (Figures S4–S6); HR-ESI-MS [M – H]– 193.0505 (calcd for C10H9O4, 193.0506).
Demethylcitreoviranol (3): White powder; [ α ] D 20 –47° (c 0.09, MeOH); UV (MeOH) λmax (logε) 302 (3.56), 271 (3.85), 212 (4.11); CD (0.54 mM, MeOH) λmax (Δε) 199 (–6.56), 236 (−0.96), 272 (–0.97), 306 (+0.75); 1H and 13C-NMR data, see Supplementary Data (Figures S8–S10); HR-ESI-MS [M + Na]+ 303.0836 (calcd for C14H15O6Na, 303.0839).
Asterriquinone F (6): White powder; [ α ] D 20 +47° (c 0.04, MeOH); UV (MeOH) λmax (logε) 281 (4.19), 221 (4.80), 200 (4.79); CD (0.092 mM, MeOH) λmax (Δε) 195 (+14.98), 201 (−9.35), 208 (+15.19), 230 (−38.81), 274 (−5.90), 319 (+18.21); 1H and 13C-NMR data, see Table 1 and Supplementary Data (Figures S12–S18); HR-ESI-MS [M + Na]+ 439.1257 (calcd for C24H20N2O5Na, 439.1264).

4.5. DPPH Radical Scavenger Assay

The DPPH radical scavenging activities of the compounds were tested as described [70].
The compounds were dissolved in MeOH, and the solutions (120 µL) were dispensed into wells of a 96-well microplate. In all, 30 µL of the DPPH (Sigma-Aldrich, Steinheim, Germany) solution in MeOH (7.5 × 10−3 M) was added to each well. The concentrations of the test compounds in the mixtures were 10 and 100 µM. The mixtures were shaken and left to stand for 30 min, and the absorbance of the resulting solutions was measured at 520 nm with a microplate reader MultiscanFC (ThermoScientific, Waltham, MA, USA). The concentration scavenging 50% of the DPPH radical (EC50) was calculated for each investigated compound.

4.6. Bioassays

4.6.1. Cell Culture

The murine neuroblastoma cell line Neuro-2a was purchased from ATCC.
Neuro-2a cells were cultured in DMEM medium containing 10% fetal bovine serum (Biolot, St. Petersburg, Russia) and 1% penicillin/streptomycin (Biolot, St. Petersburg, Russia). Cells were incubated at 37 °C in a humidified atmosphere containing 5% (v/v) CO2 [71].

4.6.2. Cytotoxicity Assay

The in vitro cytotoxicity of the individual substances was evaluated using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, which was performed according to the manufacturer’s instructions (Sigma-Aldrich, USA). Absorbance of the converted formazan was measured using a Multiskan FC plate photometer (Thermo Scientific, Waltham, MA, USA) at λ = 570 nm. The results were presented as percent of control data, and concentration of cell viability inhibition on 50% (IC50) was calculated [71].

4.6.3. Neurotoxin-Induced Cell Models of Parkinson’s Disease

The neuroblastoma Neuro-2a line cells (1 × 104 cells/well) were treated with the test compounds at concentrations of 1 and/or 10 µM for 1 h, and then the neurotoxins were added to the neuroblastoma cell suspensions [17]. Rotenone (Sigma-Aldrich, USA) was used at the concentration of 10 µM. Paraquat (Sigma-Aldrich, USA) was used at 500 µM. 6-Hydroxydopamine (Sigma-Aldrich, USA) was used at 50 µM. Cells incubated without neurotoxins and the test compounds and cells incubated with neurotoxins only were used as positive and negative controls, respectively. After 24 h of incubation, the cell viabilities were measured using the MTT method. The results are presented as the percent of positive control data.

4.6.4. ROS Level Studying in Neurotoxin-Treated Neuro-2a Cells

The cells (1 × 104 cells/well of a 96-well plate) were incubated with compound solutions (10 µM) during 1 h. Then, 6-OHDA/PQ/rotenone were added to cell suspension to resulting concentration of 50 µM, 500 µM and 10 µM respectively for incubation during 1 h. Cells incubated without neurotoxins and compounds and with neurotoxins alone were used as positive and negative controls, respectively. The 20 µL of 2,7-dichlorodihydrofluorescein diacetate solution (H2DCFDA, Molecular Probes, Eugene, OR, USA) was added to each well (10 µM, final concentration) and the plate was incubated for an additional 10 min at 37 °C. The intensity of dichlorofluorescein fluorescence was measured with PHERAstar FS plate reader (BMG Labtech, Ortenberg, Germany) at λex = 485 nm and λem = 518 nm. The data were processed by MARS Data Analysis v. 3.01R2 (BMG Labtech, Germany). The results were presented as the percent of positive control data [71].

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/18/12/608/s1. Figures S1, S2, S4–S6, S8–S10, S12–S18, S20–S39: NMR spectra of compounds 1–16, Figures S3, S7, S11, S19: CD spectra of compounds 1–3 and 6, Tables S1–S4: NMR data for compounds 7–14.

Author Contributions

Conceptualization, S.S.A. and E.A.Y.; Data curation, E.V.G., A.N.Y. and P.T.H.T.; Formal analysis, A.N.Y.; Funding acquisition, S.S.A.; Investigation, E.V.G., A.N.Y., O.F.S., P.T.H.T., N.T.D.N., M.V.P., R.S.P., E.A.P., E.S.M., E.A.C. and E.A.Y.; Methodology, S.S.A. and E.A.Y.; Project administration, S.S.A.; Resources, P.T.H.T.; Supervision, S.S.A.; Visualization, E.V.G., A.N.Y. and E.A.Y.; Writing—Original draft, E.V.G., A.N.Y., P.T.H.T. and E.A.Y.; Writing—Review and editing, S.S.A. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Russian Foundation for Basic Research (grant No 19-53-54002). The study was carried out on the equipment of the Collective Facilities Center “The Far Eastern Center for Structural Molecular Research (NMR/MS) PIBOC FEB RAS”.

Acknowledgments

Authors are grateful to Anatoly I. Kalinovsky and Anton B. Rasin (PIBOC FEB RAS, Vladivostok, Russia) for obtaining of NMR spectra and Natalya Yu. Kim (PIBOC FEB RAS, Vladivostok, Russia) for obtaining of ECD data.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hasan, S.; Ansari, M.; Ahmad, A.; Mishra, M. Major bioactive metabolites from marine fungi: A Review. Bioinformation 2015, 11, 176–181. [Google Scholar] [CrossRef] [PubMed]
  2. Sridhar, K.R. Marine filamentous fungi: Diversity, distribution and bioprospecting. In Developments in Fungal Biology and Applied Mycology; Springer: Singapore, 2017; pp. 59–73. [Google Scholar]
  3. Langenfeld, A.; Blond, A.; Gueye, S.; Herson, P.; Nay, B.; Dupont, J.; Prado, S. Insecticidal cyclodepsipeptides from Beauveria felina. J. Nat. Prod. 2011, 74, 825–830. [Google Scholar] [CrossRef] [PubMed]
  4. Yurchenko, A.N.; Smetanina, O.F.; Kalinovsky, A.I.; Pushilin, M.A.; Glazunov, V.P.; Khudyakova, Y.V.; Kirichuk, N.N.; Ermakova, S.P.; Dyshlovoy, S.A.; Yurchenko, E.A.; et al. Oxirapentyns F-K from the Marine-Sediment-Derived Fungus Isaria felina KMM 4639. J. Nat. Prod. 2014, 77, 1321–1328. [Google Scholar] [CrossRef] [PubMed]
  5. Gladfelter, A.S.; James, T.Y.; Amend, A.S. Marine fungi. Curr. Biol. 2019, 29, R191–R195. [Google Scholar] [CrossRef]
  6. Trang, T.T.M.; Ha, N.T.N.; Thanh, T.D. Position resources in the coastal area of Khanh Hoa province: Potential and prospects. Vietnam J. Mar. Sci. Technol. 2015, 15, 13–24. [Google Scholar] [CrossRef]
  7. Marin, I.; Savinkin, O.; Britayev, T.; Pavlov, D. Benthic fauna of the Bay of Nhatrang, Southern Vietnam; KMK Scientific Press: Moscow, Russia, 2007; Volume 2, p. 235. [Google Scholar]
  8. Dung, L.D. Nha Trang Bay marine protected area, Vietnam: Initial trends in coral structure and some preliminary linkages between these trends and human activities (2002–2005). Aquat. Ecosyst. Health Manag. 2009, 12, 249–257. [Google Scholar] [CrossRef]
  9. Latypov, Y.Y. Scleractinian corals and reefs of Vietnam as a part of the Pacific reef ecosystem. Open J. Mar. Sci. 2011, 1, 50. [Google Scholar] [CrossRef] [Green Version]
  10. Latypov, Y.Y. Some Data on the Composition and Structure of Coral Communities in the Littoral and Sublittoral in the Province of Khanh Hoa, Vietnam. J. Mar. Sci. Res. Dev. 2014, 4, 1. [Google Scholar] [CrossRef]
  11. Smetanina, O.F.; Yurchenko, A.N.; Afiyatullov, S.S.; Kalinovsky, A.I.; Pushilin, M.A.; Khudyakova, Y.V.; Slinkina, N.N.; Ermakova, S.P.; Yurchenko, E.A. Oxirapentyns B-D produced by a marine sediment-derived fungus Isaria felina (DC.) Fr. Phytochem. Lett. 2012, 5, 165–169. [Google Scholar] [CrossRef]
  12. Smetanina, O.F.; Yurchenko, A.N.; Ivanets, E.V.; Kalinovsky, A.I.; Khudyakova, Y.V.; Dyshlovoy, S.A.; Von Amsberg, G.; Yurchenko, E.A.; Afiyatullov, S.S. Unique prostate cancer-toxic polyketides from marine sediment-derived fungus Isaria felina. J. Antibiot. 2017, 70, 856–858. [Google Scholar] [CrossRef]
  13. Zhuravleva, O.I.; Kirichuk, N.N.; Denisenko, V.A.; Dmitrenok, P.S.; Yurchenko, E.A.; Min’ko, E.M.; Ivanets, E.V.; Afiyatullov, S.S. New Diorcinol J Produced by Co-Cultivation of Marine Fungi Aspergillus sulphureus and Isaria felina. Chem. Nat. Compd. 2016, 52, 227–230. [Google Scholar] [CrossRef]
  14. Yurchenko, A.N.; Smetanina, O.F.; Kirichuk, N.N.; Yurchenko, E.A.; Afiyatullov, S.S. Biologically Active Metabolites of the Facultative Marine Fungus Aspergillus terreus. Chem. Nat. Compd. 2014, 49, 1123–1124. [Google Scholar] [CrossRef]
  15. Yurchenko, A.N.; Smetanina, O.F.; Ivanets, E.V.; Phan, T.T.H.; Ngo, N.T.D.; Zhuravleva, O.I.; Rasin, A.B.; Dyshlovoy, S.A.; Menchinskaya, E.S.; Pislyagin, E.A.; et al. Auroglaucin-related neuroprotective compounds from Vietnamese marine sediment-derived fungus Aspergillus niveoglaucus. Nat. Prod. Res. 2020, 34, 2589–2594. [Google Scholar] [CrossRef]
  16. Smetanina, O.F.; Yurchenko, A.N.; Ivanets, E.V.G.; Trinh, P.T.; Antonov, A.S.; Dyshlovoy, S.A.; Von Amsberg, G.; Kim, N.Y.; Chingizova, E.A.; Pislyagin, E.A.; et al. Biologically active echinulin-related indolediketopiperazines from the marine sediment-derived fungus Aspergillus niveoglaucus. Molecules 2020, 25, 61. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Yurchenko, E.A.; Menchinskaya, E.S.; Pislyagin, E.A.; Trinh, P.T.H.; Ivanets, E.V.; Smetanina, O.F.; Yurchenko, A.N. Neuroprotective Activity of Some Marine Fungal Metabolites in the 6-Hydroxydopamin- and Paraquat-Induced Parkinson’s Disease Models. Mar. Drugs 2018, 16, 457. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Yurchenko, A.N.; Trinh, P.T.H.; Girich, E.V.; Smetanina, O.F.; Rasin, A.B.; Popov, R.S.; Dyshlovoy, S.A.; von Amsberg, G.; Menchinskaya, E.S.; Thanh Van, T.T.; et al. Biologically Active Metabolites from the Marine Sediment-Derived Fungus Aspergillus flocculosus. Mar. Drugs 2019, 17, 579. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Shin, H.J.; Choi, B.K.; Trinh, P.T.H.; Lee, H.S.; Kang, J.S.; Van, T.T.T.; Lee, H.S.; Lee, J.S.; Lee, Y.J.; Lee, J. Suppression of RANKL-induced osteoclastogenesis by the metabolites from the marine fungus Aspergillus flocculosus isolated from a sponge Stylissa sp. Mar. Drugs 2018, 16, 14. [Google Scholar] [CrossRef] [Green Version]
  20. Lorenz, P.; Jensen, P.R.; Fenical, W. Mactanamide, a new fungistatic diketopiperazine produced by a marine Aspergillus sp. Nat. Prod. Lett. 1998, 12, 55–60. [Google Scholar] [CrossRef]
  21. Dao, D.Q.; Phan, T.T.T.; Nguyen, T.L.A.; Trinh, P.T.H.; Tran, T.T.V.; Lee, J.S.; Shin, H.J.; Choi, B.K. Insight into Antioxidant and Photoprotective Properties of Natural Compounds from Marine Fungus. J. Chem. Inf. Model. 2020, 60, 1329–1351. [Google Scholar] [CrossRef]
  22. Smetanina, O.F.; Yurchenko, A.N.; Ivanets, E.V.; Gerasimenko, A.V.; Trinh, P.T.H.; Ly, B.M.; Nhut, N.D.; Van, T.T.T.; Yurchenko, E.A.; Afiyatullov, S.S. Aromatic Metabolites of Marine Fungus Penicillium sp. KMM 4672 Associated with a Brown Alga Padina sp. Chem. Nat. Compd. 2017, 53, 600–602. [Google Scholar] [CrossRef]
  23. Iwasaki, S.; Muro, H.; Sasaki, K.; Nozoe, S.; Okuda, S.; Sato, Z. Isolations of phytotoxic substances produced by Pyricularia oryzae Cavara. Tetrahedron Lett. 1973, 14, 3537–3542. [Google Scholar] [CrossRef]
  24. Iwasaki, S.; Muro, H.; Nozoe, S.; Okuda, S.; Sato, Z. Isolation of 3,4-dihydro-3,4,8-trihydroxy-1(2H)-naphthalenone and tenuazonic acid from Pyricularia oryzae cavara. Tetrahedron Lett. 1972, 13, 13–16. [Google Scholar] [CrossRef]
  25. Shizuri, Y.; Shigemori, H.; Sato, R.; Yamamura, S.; Kawai, K.; Furukawa, H. Four new metabolites produced by Penicillium citreo-viride B. on addition of NaBr. Chem. Lett. 1988, 17, 1419–1422. [Google Scholar] [CrossRef]
  26. Bürki, N.; Michel, A.; Tabacchi, R. Naphthalenones and isocoumarins of the fungus Ceratocystis fimbriata f. sp. platani. Phytopathol. Mediterr. 2003, 42, 191–198. [Google Scholar]
  27. Pittayakhajonwut, P.; Sohsomboon, P.; Dramae, A.; Suvannakad, R.; Lapanun, S.; Tantichareon, M. Antimycobacterial substances from Phaeosphaeria sp. BCC8292. Planta Med. 2008, 74, 281–286. [Google Scholar] [CrossRef] [PubMed]
  28. Quach, R.; Furkert, D.P.; Brimble, M.A. Total Synthesis of the Resorcyclic Acid Lactone Spiroketal Citreoviranol. J. Org. Chem. 2016, 81, 8343–8350. [Google Scholar] [CrossRef] [PubMed]
  29. Zhang, P.; Li, X.M.; Mao, X.X.; Mandi, A.; Kurtan, T.; Wang, B.G. Varioloid A, a new indolyl-6,10b-dihydro-5aH-[1]benzofuro[2,3-b]indole derivative from the marine alga-derived endophytic fungus Paecilomyces variotii EN-291. Beilstein J. Org. Chem. 2016, 12, 2012–2018. [Google Scholar] [CrossRef] [Green Version]
  30. Zhang, P.; Li, X.M.; Mao, X.X.; Mándi, A.; Kurtán, T.; Wang, B.G. Correction: Varioloid A, a new indolyl-6,10b-dihydro-5aH-[1]benzofuro[2,3-b]indole derivative from the marine alga-derived endophytic fungus Paecilomyces variotii EN-291 (Beilstein Journal of Organic Chemistry (2016) 12 (2012–2018) doi:10.3762/bjoc.12.188). Beilstein J. Org. Chem. 2018, 14, 2394–2395. [Google Scholar]
  31. Arai, K.; Shimizu, S.; Yamamoto, Y. Metabolic Products of Aspregillus terreus. VI. Metabolites of the Strain IFO 8835. (3). The Isolation and Chemical Structures of Colorless Metabolites. Chem. Pharm. Bull. 1981, 29, 1005–1012. [Google Scholar] [CrossRef] [Green Version]
  32. Arai, K.; Yamamoto, Y. Metabolic Products of Aspergillus terreus X: Biosynthesis of Asterriquinones. Chem. Pharm. Bull. 1990, 38, 2929–2932. [Google Scholar] [CrossRef] [Green Version]
  33. Arai, K.; Masuda, K.; Kiriyama, N.; Nitta, K.; Yamamoto, Y.; Shimizu, S. Metabolic Products of Aspergillus terreus. IV. Metabolites of the Strain IFO 8835. (2). The Isolation and Chemical Structure of Indolyl Benzoquinone Pigments. Chem. Pharm. Bull. 1981, 29, 961–969. [Google Scholar] [CrossRef] [Green Version]
  34. Mahmoodian, A.; Stickings, C.E. Studies in the biochemistry of micro-organisms. 115. Metabolites of Penicillium frequentans Westling: Isolation of sulochrin, asterric acid, (+)-bisdechlorogeodin and two new substituted anthraquinones, questin and questinol. Biochem. J. 1964, 92, 369–378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Inamori, Y.; Kato, Y.; Kubo, M.; Kamiki, T.; Takemoto, T.; Nomoto, K. Studies on metabolites produced by Aspergillus terreus var. aureus. I. Chemical structures and antimicrobial activities of metabolites isolated from culture broth. Chem. Pharm. Bull. 1983, 31, 4543–4548. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Cameron, D.W.; Coller, D.R. Regioselective Synthesis of O-Methyl Derivatives of the Trihydroxy Anthraquinones Morindone and Nataloe-Emodin. Aust. J. Chem. 1999, 52, 941–948. [Google Scholar] [CrossRef]
  37. Hansson, D.; Menkis, A.; Olson, K.; Stenlid, J.; Broberg, A.; Karlsson, M. Biosynthesis of fomannoxin in the root rotting pathogen Heterobasidion occidentale. Phytochemistry 2012, 84, 31–39. [Google Scholar] [CrossRef]
  38. Li, H.L.; Li, X.M.; Yang, S.Q.; Meng, L.H.; Li, X.; Wang, B.G. Prenylated Phenol and Benzofuran Derivatives from Aspergillus terreus EN-539, an Endophytic Fungus Derived from Marine Red Alga Laurencia okamurai. Mar. Drugs 2019, 17, 605. [Google Scholar] [CrossRef] [Green Version]
  39. Calton, G.J.; Ranieri, R.L.; Espenshade, M.A. Quadrone, a new antitumor substance produced by Aspergillus terreus. Production, isolation and properties. J. Antibiot. 1978, 31, 38–42. [Google Scholar] [CrossRef]
  40. Hao, J.-d.; Zheng, J.-j.; Chen, M.; Wang, C.-y. Cytochalasins from the Gorgonian-Derived Fungus Aspergillus sp. XS-2009-0B15. Chem. Nat. Compd. 2017, 53, 732–735. [Google Scholar] [CrossRef]
  41. Swarnkar, S.; Goswami, P.; Kamat, P.K.; Gupta, S.; Patro, I.K.; Singh, S.; Nath, C. Rotenone-induced apoptosis and role of calcium: A study on Neuro-2a cells. Arch. Toxicol. 2012, 86, 1387–1397. [Google Scholar] [CrossRef]
  42. Pantiya, P.; Thonusin, C.; Chattipakorn, N.; Chattipakorn, S.C. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer’s disease, Parkinson’s disease, Huntington’s disease. Mitochondrion 2020, 55, 14–47. [Google Scholar] [CrossRef]
  43. Hirota, A.; Nemoto, A.; Tsuchiya, Y.; Hojo, H.; Abe, N. Isolation of a 2-pyrone compound as an antioxidant from a fungus and its new reaction product with 1,1-diphenyl-2-picrylhydrazyl radical. Biosci. Biotechnol. Biochem. 1999, 63, 418–420. [Google Scholar] [CrossRef] [PubMed]
  44. Li, D.L.; Li, X.M.; Wang, B.G. Natural anthraquinone derivatives from a marine mangrove plant-derived endophytic fungus Eurotium rubrum: Structural elucidation and DPPH radical scavenging activity. J. Microbiol. Biotechnol. 2009, 19, 675–680. [Google Scholar] [PubMed]
  45. Greenblatt, G.A.; Wheeler, M.H. HPLC Analysis of Fungal Melanin Intermediates and Related Metabolites. J. Liq. Chromatogr. 1986, 9, 971–981. [Google Scholar] [CrossRef]
  46. Han, X.; Hu, H.; Luo, Y.; Deng, Y. Chemical constituents of Penicillium oxalicum, an endophytic fungus isolated from Bletilla striata (Thunb.) Reichb. f. Chin. J. Appl. Environ. Biol. 2019, 25, 438–444. [Google Scholar]
  47. Medina, R.P.; Araujo, A.R.; Andersen, R.J.; Soares, M.A.; Silva, F.A.; Silva, D.H.S. Aromatic compounds produced by endophytic fungi isolated from red alga Asparagopsis taxiformis—Falkenbergia stage. Nat. Prod. Res. 2019, 33, 443–446. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Stierle, A.A.; Upadhyay, R.; Hershenhorn, J.; Strobel, G.A.; Molina, G. The phytotoxins of Mycosphaerella fijiensis, the causative agent of Black Sigatoka disease of bananas and plantains. Experientia 1991, 47, 853–859. [Google Scholar] [CrossRef]
  49. Cimmino, A.; Maddau, L.; Masi, M.; Evidente, M.; Linaldeddu, B.T.; Evidente, A. Further secondary metabolites produced by Diplodia corticola, a fungal pathogen involved in cork oak decline. Tetrahedron 2016, 72, 6788–6793. [Google Scholar] [CrossRef]
  50. Zhu, Y.; Dong, J.; Wang, L.; Zhou, W.; Li, L.; He, H.; Liu, H.; Zhang, K. Screening and isolation of antinematodal metabolites against Bursaphelenchus xylophilus produced by fungi. Ann. Microbiol. 2008, 58, 375–380. [Google Scholar] [CrossRef]
  51. Wang, Y.; Liu, H.X.; Chen, Y.C.; Sun, Z.H.; Li, H.H.; Li, S.N.; Yan, M.L.; Zhang, W.M. Two new metabolites from the endophytic fungus Alternaria sp. A744 derived from Morinda officinalis. Molecules 2017, 22, 765. [Google Scholar] [CrossRef] [Green Version]
  52. Conti, R.; Chagas, F.O.; Caraballo-Rodriguez, A.M.; Melo, W.G.D.P.; do Nascimento, A.M.; Cavalcanti, B.C.; de Moraes, M.O.; Pessoa, C.; Costa-Lotufo, L.V.; Krogh, R.; et al. Endophytic Actinobacteria from the Brazilian Medicinal Plant Lychnophora ericoides Mart. and the Biological Potential of Their Secondary Metabolites. Chem. Biodivers. 2016, 13, 727–736. [Google Scholar] [CrossRef]
  53. Huang, R.; Wang, T.; Xie, X.S.; Ma, K.X.; Fang, X.W.; Wu, S.H. Secondary Metabolites from an Endophytic Fungus Nigrospora sp. Chem. Nat. Compd. 2016, 52, 697–699. [Google Scholar] [CrossRef]
  54. Zhao, Y.; Liu, D.; Proksch, P.; Yu, S.; Lin, W. Isocoumarin Derivatives from the Sponge-Associated Fungus Peyronellaea glomerata with Antioxidant Activities. Chem. Biodivers. 2016, 13, 1186–1193. [Google Scholar] [CrossRef] [PubMed]
  55. Liu, N.; Peng, S.; Yang, J.; Cong, Z.; Lin, X.; Liao, S.; Yang, B.; Zhou, X.; Zhou, X.; Liu, Y.; et al. Structurally diverse sesquiterpenoids and polyketides from a sponge-associated fungus Aspergillus sydowii SCSIO41301. Fitoterapia 2019, 135, 27–32. [Google Scholar] [CrossRef] [PubMed]
  56. Orfali, R.S.; Aly, A.H.; Ebrahim, W.; Proksch, P. Isochroman and isocoumarin derivatives from hypersaline lake sediment-derived fungus Penicillium sp. Phytochem. Lett. 2015, 13, 234–238. [Google Scholar] [CrossRef]
  57. Abe, N.; Nemoto, A.; Tsuchiya, Y.; Hojo, H.; Hirota, A. Studies on the 1,1-Diphenyl-2-picrylhydrazyl Radical Scavenging Mechanism for a 2-Pyrone Compound. Biosci. Biotechnol. Biochem. 2000, 64, 306–313. [Google Scholar] [CrossRef] [PubMed]
  58. Chen, X.W.; Li, C.W.; Cui, C.B.; Hua, W.; Zhu, T.J.; Gu, Q.Q. Nine new and five known polyketides derived from a deep sea-sourced Aspergillus sp. 16-02-1. Mar. Drugs 2014, 12, 3116–3137. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Kito, K.; Ookura, R.; Yoshida, S.; Namikoshi, M.; Ooi, T.; Kusumi, T. Pentaketides relating to aspinonene and dihydroaspyrone from a marine-derived fungus, Aspergillus ostianus. J. Nat. Prod. 2007, 70, 2022–2025. [Google Scholar] [CrossRef]
  60. Tawfike, A.F.; Romli, M.; Clements, C.; Abbott, G.; Young, L.; Schumacher, M.; Diederich, M.; Farag, M.; Edrada-Ebel, R. Isolation of anticancer and anti-trypanosome secondary metabolites from the endophytic fungus Aspergillus flocculus via bioactivity guided isolation and MS based metabolomics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2019, 1106–1107, 71–83. [Google Scholar] [CrossRef] [Green Version]
  61. Liu, Y.; Li, X.M.; Meng, L.H.; Wang, B.G. Polyketides from the marine mangrove-derived fungus Aspergillus ochraceus MA-15 and their activity against aquatic pathogenic bacteria. Phytochem. Lett. 2015, 12, 232–236. [Google Scholar] [CrossRef]
  62. Lin, B.; Pirrung, M.C.; Deng, L.; Li, Z.; Liu, Y.; Webster, N.J.G. Neuroprotection by small molecule activators of the nerve growth factor receptor. J. Pharm. Exp. 2007, 322, 59–69. [Google Scholar] [CrossRef] [Green Version]
  63. Webster, N.J.G.; Pirrung, M.C. Small molecule activators of the Trk receptors for neuroprotection. BMC Neurosci. 2008, 9, S1. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Yang, L.H.; Ou-Yang, H.; Yan, X.; Tang, B.W.; Fang, M.J.; Wu, Z.; Chen, J.W.; Qiu, Y.K. Open-Ring Butenolides from a Marine-Derived Anti-Neuroinflammatory Fungus Aspergillus terreus Y10. Mar. Drugs 2018, 16, 428. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Zhang, Y.Y.; Zhang, Y.; Yao, Y.B.; Lei, X.L.; Qian, Z.J. Butyrolactone-i from coral-derived fungus Aspergillus terreus attenuates neuro-inflammatory response via suppression of NF-κB pathway in BV-2 cells. Mar. Drugs 2018, 16, 202. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Kang, H.S.; Kim, J.P. Butenolide derivatives from the fungus Aspergillus terreus and their radical scavenging activity and protective activity against glutamate-induced excitotoxicity. Appl. Biol. Chem. 2019, 62, 43. [Google Scholar] [CrossRef]
  67. El-Agamy, D.S.; Ibrahim, S.R.M.; Ahmed, N.; Khoshhal, S.; Abo-Haded, H.M.; Elkablawy, M.A.; Aljuhani, N.; Mohamed, G.A. Aspernolide F, as a new cardioprotective butyrolactone against doxorubicin-induced cardiotoxicity. Int. Immunopharmacol. 2019, 72, 429–436. [Google Scholar] [CrossRef]
  68. Stien, D. Marine microbial diversity as a source of bioactive natural products. Mar. Drugs 2020, 18, 215. [Google Scholar] [CrossRef]
  69. Yurchenko, A.; Smetanina, O.; Ivanets, E.; Kalinovsky, A.; Khudyakova, Y.; Kirichuk, N.; Popov, R.; Bokemeyer, C.; von Amsberg, G.; Chingizova, E.; et al. Pretrichodermamides D–F from a Marine Algicolous Fungus Penicillium sp. KMM 4672. Mar. Drugs 2016, 14, 122. [Google Scholar] [CrossRef]
  70. Leutou, A.S.; Yun, K.; Son, B.W. Induced production of 6,9-dibromoflavasperone, a new radical scavenging naphthopyranone in the marine-mudflat-derived fungus Aspergillus niger. Arch. Pharmacal Res. 2016, 39, 806–810. [Google Scholar] [CrossRef]
  71. Lyakhova, E.G.; Kolesnikova, S.A.; Kalinovsky, A.I.; Berdyshev, D.V.; Pislyagin, E.A.; Kuzmich, A.S.; Popov, R.S.; Dmitrenok, P.S.; Makarieva, T.N.; Stonik, V.A. Lissodendoric acids A and B, manzamine-related alkaloids from the far eastern sponge Lissodendoryx florida. Org. Lett. 2017, 19, 5320–5323. [Google Scholar] [CrossRef]
Marinedrugs 18 00608 g001 550
Figure 1. Structures of isolated compounds.
Figure 1. Structures of isolated compounds.
Marinedrugs 18 00608 g001
Marinedrugs 18 00608 g002 550
Figure 2. The key HMBC (shown by arrows) and 1H-1H COSY (shown by bold bonds) correlations in different moieties of 6 (a, b—Indole moieties, c—hydroquinone moiety, d—whole molecule).
Figure 2. The key HMBC (shown by arrows) and 1H-1H COSY (shown by bold bonds) correlations in different moieties of 6 (a, b—Indole moieties, c—hydroquinone moiety, d—whole molecule).
Marinedrugs 18 00608 g002
Marinedrugs 18 00608 g003a 550Marinedrugs 18 00608 g003b 550
Figure 3. Influence of compounds 1–3 on viability of Neuro-2a cells treated with 6-OHDA (a), PQ (c) and rotenone (e). Influence of compounds 1–3 on ROS level in cells treated with 6-OHDA (b), PQ (d) and rotenone (f). * Differences are significant with p ≤ 0.05.
Figure 3. Influence of compounds 1–3 on viability of Neuro-2a cells treated with 6-OHDA (a), PQ (c) and rotenone (e). Influence of compounds 1–3 on ROS level in cells treated with 6-OHDA (b), PQ (d) and rotenone (f). * Differences are significant with p ≤ 0.05.
Marinedrugs 18 00608 g003aMarinedrugs 18 00608 g003b
Marinedrugs 18 00608 g004a 550Marinedrugs 18 00608 g004b 550
Figure 4. Influence of compounds 4 and 5 on viability of Neuro-2a cells treated with 6-OHDA (a), PQ (c) and rotenone (e). Influence of compounds 4 and 5 on the ROS level in cells treated with 6-OHDA (b), PQ (d) and rotenone (f). * Differences are significant with p ≤ 0.05. ** Differences are significant with p ≤ 0.10.
Figure 4. Influence of compounds 4 and 5 on viability of Neuro-2a cells treated with 6-OHDA (a), PQ (c) and rotenone (e). Influence of compounds 4 and 5 on the ROS level in cells treated with 6-OHDA (b), PQ (d) and rotenone (f). * Differences are significant with p ≤ 0.05. ** Differences are significant with p ≤ 0.10.
Marinedrugs 18 00608 g004aMarinedrugs 18 00608 g004b
Marinedrugs 18 00608 g005 550
Figure 5. Influence of compounds 6–12 on viability of Neuro-2a cells treated with 6-OHDA (a), PQ (c) and rotenone (e). Influence of compounds 6–12 on ROS level in Neuro-2a cells treated with 6-OHDA (b), PQ (d) and rotenone (f). * Differences are significant with p ≤ 0.05. ** Differences are significant with p ≤ 0.10.
Figure 5. Influence of compounds 6–12 on viability of Neuro-2a cells treated with 6-OHDA (a), PQ (c) and rotenone (e). Influence of compounds 6–12 on ROS level in Neuro-2a cells treated with 6-OHDA (b), PQ (d) and rotenone (f). * Differences are significant with p ≤ 0.05. ** Differences are significant with p ≤ 0.10.
Marinedrugs 18 00608 g005
Table
Table 1. 1H and 13C NMR spectroscopic data (δ in ppm, CDCl3) for 6.
Table 1. 1H and 13C NMR spectroscopic data (δ in ppm, CDCl3) for 6.
Pos.δC, multδH, (J in Hz)HMBCCOSY
1141.3, C
2116.7, C
3138.4, C
4144.9, C
5121.6, C
6139.1, C
6-OMe61.5, CH34.12, s6
3-OMe60.4, CH33.58, s3
2’104.6, CH6.24, s 4, 5, 3’, 3a’, 7a’
3’90.3, C
3a’129.7, C
4’125.0, CH7.78, d (7.5)3’, 6’, 7’, 7a’5’
5’120.1, CH6.88, t (7.5)3a’, 4’, 7’4’, 6’
6’130.1, CH7.18, t (7.8)3a’, 4’, 7’, 7a’5’, 7’
7’109.9, CH6.70, d (8.0)3a’, 5’6’
7a’148.6, C
1”(NH)8.44, brs3”2”
2”124.8, CH7.29, d (2.4)2, 3”, 3a’’, 7a’’3’’
3”106.7, C
3a’’126.5, C
4”120.3, CH7.47, d (8.1)3”, 3a’’, 5”, 6”, 7”, 7a’’5’’
5”120.4, CH7.14, t (7.5)3a’’, 7”4’’, 6’’
6”122.7, CH7.24, t (7.8)4”, 7a’’5’’, 7’’
7”111.4, CH7.43, d (8.1)3a’’, 5”, 6”6’’
7a’’136.2, C
1-OH 5.06, brs1, 2, 6
Table
Table 2. Cytotoxicity and radical scavenging activities of compounds 1–12.
Table 2. Cytotoxicity and radical scavenging activities of compounds 1–12.
CompoundsCytotoxicityDPPH Radical Scavenging
IC50, µM100 µM
% of MeOH		EC50, µM
1>10083.4 ± 1.2>100
2>10084.8 ± 3.2>100
3>10091.2 ± 1.8>100
4>10087.2 ± 1.4500 [43]
5>10095.2 ± 1.0>100
6>10067.3 ± 3.9>100
7>10088.9 ± 1.6>100
891.45 ± 1.8789.5 ± 0.9>100
942.32 ± 1.4582.4 ± 1.7>100
10>10091.3 ± 1.1>100
11>10085.6 ± 1.3>100
12>10087.7 ± 2.4>100
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Girich, E.V.; Yurchenko, A.N.; Smetanina, O.F.; Trinh, P.T.H.; Ngoc, N.T.D.; Pivkin, M.V.; Popov, R.S.; Pislyagin, E.A.; Menchinskaya, E.S.; Chingizova, E.A.; et al. Neuroprotective Metabolites from Vietnamese Marine Derived Fungi of Aspergillus and Penicillium Genera. Mar. Drugs 2020, 18, 608. https://doi.org/10.3390/md18120608

AMA Style

Girich EV, Yurchenko AN, Smetanina OF, Trinh PTH, Ngoc NTD, Pivkin MV, Popov RS, Pislyagin EA, Menchinskaya ES, Chingizova EA, et al. Neuroprotective Metabolites from Vietnamese Marine Derived Fungi of Aspergillus and Penicillium Genera. Marine Drugs. 2020; 18(12):608. https://doi.org/10.3390/md18120608

Chicago/Turabian Style

Girich, Elena V., Anton N. Yurchenko, Olga F. Smetanina, Phan Thi Hoai Trinh, Ngo Thi Duy Ngoc, Mikhail V. Pivkin, Roman S. Popov, Evgeny A. Pislyagin, Ekaterina S. Menchinskaya, Ekaterina A. Chingizova, and et al. 2020. "Neuroprotective Metabolites from Vietnamese Marine Derived Fungi of Aspergillus and Penicillium Genera" Marine Drugs 18, no. 12: 608. https://doi.org/10.3390/md18120608

APA Style

Girich, E. V., Yurchenko, A. N., Smetanina, O. F., Trinh, P. T. H., Ngoc, N. T. D., Pivkin, M. V., Popov, R. S., Pislyagin, E. A., Menchinskaya, E. S., Chingizova, E. A., Afiyatullov, S. S., & Yurchenko, E. A. (2020). Neuroprotective Metabolites from Vietnamese Marine Derived Fungi of Aspergillus and Penicillium Genera. Marine Drugs, 18(12), 608. https://doi.org/10.3390/md18120608

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop